JNJ26489112

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ26489112, covering 2025-04-29 to 2025-04-29. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of JNJ26489112 in Patients With Treatment-Resistant Major Depressive Disorder [Phase 2]

See pricing